Pfizer Inc. (PFE), United Therapeutics Corporation (UTHR): Organovo Holdings Inc (ONVO)’s Earnings, Patience Is Necessary

Apparently, the market agrees. Earlier this month, Organovo offered about 10.4 million new shares to the market, raising about $43.3 million for the company. That was 1.35 million more than was originally allotted due to increased demand.

Personally, I think it’s worthwhile for investors interested in the space to consider buying shares; I announced I would be doing as much last week. But I cannot stress enough that my allocation will be very tiny — less than 1% of my overall holdings.

By buying, I’m encouraging myself to follow the company and buy in when news of drug companies buying in comes to the fore. Of course, that will probably mean I’ll have to pay more for shares, but that’s OK — because there’s always a chance that the company’s stock could go to zero.

The article Organovo’s Earnings: Patience Is Necessary originally appeared on Fool.com and is written by Brian Stoffel.

Fool contributor Brian Stoffel has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.